Gentamicins

ApprovedSmall molecule

UUniversity of Chicago

Gentamicins is one of 32 small molecule programs targeting Schwannoma. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

SchwannomaActive, not recruiting

PneumoniaActive, not recruiting

SchwannomaApproved

Active, not recruiting

PneumoniaPreclinical

Active, not recruiting

Competition

Competitive Landscape

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

Gentamicins

UUniversity of Chicago

Approved

1 2

Innohep

Alnylam Pharmaceuticals

Preclinical

1 3

Neutrexin

WWest Japan Thoracic Oncology Group

Preclinical

12 4

Zantac 150

CChattem

Preclinical

2 5

Alka-Seltzer

AAbbott

Preclinical

1 6

Pepcid

KKenvue Brands

Preclinical

1 7

Aciphex

Akero Therapeutics

Preclinical

1 8

Protonix

WWyeth-Lederle Vaccines

Preclinical

1 9

Mucinex

AAultman Health Foundation

Preclinical

1 10

Tylenol

KKenvue Brands

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Antibiotic Therapy1 trial

Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)

Unknown status·AAzienda Sanitaria-Universitaria Integrata di Udine··NCT04132115·104 enrolled

Schwannoma1 trial

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

Withdrawn·LLund University·Phase 4·NCT02379754

Randomized Controlled Trial1 trial

A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome

Completed·UUniversity of Chicago·N/A·NCT02477423·27 enrolled

Pneumonia1 trial

Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin

Completed·MMaimónides Biomedical Research Institute of Córdoba··NCT02604849·44 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Gentamicins. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Gentamicins compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Gentamicins. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Chicago company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity of Chicago

Gentamicins

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Antibiotic Therapy1 trial

Schwannoma1 trial

Randomized Controlled Trial1 trial

Pneumonia1 trial

References

Drug Info

Quick Facts

Related News